BioCentury
ARTICLE | Company News

IDM SA, Jenner deal

April 14, 2003 7:00 AM UTC

Cellular immunotherapy and cancer company Immuno-Designed acquired certain cancer-related assets from Jenner in exchange for shares. The deal includes exclusive rights to a recombinant KSA antigen (EP...